Systemic replacement therapy from genetically modified epidermal keratinocytes

Proceedings of the Association of American Physicians

Volumn 111, Issue 3, 1999, Pages 206-210

  Taichman, L B ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

Apolipoprotein E; Gene expression; Retrovirus vector; Secretion; Transduction

Indexed keywords

GENE EXPRESSION; GENE TARGETING; GENE THERAPY; GENE TRANSFER; KERATINOCYTE; PROTEIN SECRETION; PROTEIN TRANSPORT; REVIEW; SUBSTITUTION THERAPY; TRANSGENE;

EID: 0032968687     PISSN: 1081650X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1381.1999.99226.x     Document Type: Review

References (37)

1. 1 Krueger G.G., Morgan J.R., Jorgensen C.M., et al. Genetically modified skin to treat disease: Potential and limitations. J. Invest. Dermatol. 103 (3): 76S 84S, 1994.
2. 2 Zaretsky J.Z., Candotti F., Boerkoel C., et al. Retroviral transfer of acid a‐glucosidase cDNA to enzyme deficient myoblasts results in phenotypic spread of the genotypic correction by both secretion and fusion. Hum. Gene Ther. 8: 1555 ‐ 1563, 1997.
3. 3 Levy M.Y., Barron L.G., Meyer K.B., Szoka Jr. F.C. Characterization of plasmid DNA transfer into mouse skeletal muscle: Evaluation of uptake mechanism, expression and secretion of gene products into blood. Gene Ther. 3: 201 211, 1997.
4. 4 Kolodka T.M., Finegold M., Moss L., Woo S.L. Gene therapy for diabetes mellitus in rats by hepatic expression of insulin. Proc. Natl. Acad. Sci. U.S.A. 92: 3293 3297, 1995.
5. 5 Nagy J.A., Shockley T.R., Masse E.M., et al. Systemic delivery of a recombinant protein by genetically modified mesothelial cells reseeded on the parietal peritoneal surface. Gene Ther. 2: 402 410, 1995.
6. 6 Murphy J.E. & Rheinwald J.G. Intraperitoneal injection of genetically modified, human mesothelial cells for systemic gene therapy [see comments]. Hum. Gene Ther. 8: 1867 1879, 1997.
7. 7 Regauer S., Seiler G.R., Barrandon Y., et al. Epithelial origin of cutaneous anchoring fibrils. J. Cell Biol. 111: 2109 2115, 1990.
8. 8 Marinkovich M.P., Keene D.R., Clytie S.R., Burgeson R.E. Cellular origin of the dermal‐epidermal basement membrane. Dev. Dyn. 197: 255 267, 1993.
9. 9 Clark R.A. Biology of dermal wound repair. Dermatol. Clin. 11: 647 666, 1993.
10. 10 DiMarco E., Marchisio P.C., Bondanze S., et al. Growth‐regulated synthesis and secretion of biologically active nerve growth factor by human keratinocytes. J. Biol. Chem. 266: 21718 21722, 1991.
11. 11 Wu T.L., Soifer N.E., Burtis W.J., et al. Glycosylation of parathyroid hormone‐related peptide secreted by human epidermal keratinocytes. J. Clin. Endocrinol. Metab. 73: 1002 1007, 1991.
12. 12 Yohn J.J., Morelli J.G., Walchak S.J., et al. Cultured human keratinocytes synthesize and secrete endothelin‐1. J. Invest. Dermatol. 100: 23 26, 1993.
13. 13 Basset‐Seguin N., Caughman S.W., Yancey K.B. A‐431 cells and human keratinocytes synthesize and secrete the third component of complement. J. Invest. Dermatol. 95: 621 625, 1990.
14. 14 Schröder J.‐M. Chemotactic cytokines in the epidermis. Exp. Dermatol. 1: 12 19, 1992.
15. 15 Celis J.E., Rasmussen H.H., Olsen E., et al. The human keratinocyte two‐dimensional protein database (update 1994): Towards an integrated approach to the study of cell proliferation, differentiation and skin diseases. Electrophoresis 15: 1349 1458, 1994.
16. 16 Breslow J.L. Human apolipoprotein molecular biology and genetic variation. Ann. Rev. Biochem. 54: 699 727, 1985.
17. 17 Gordon D.A., Fenjves E.S., Williams D.L., Taichman L.B. Synthesis and secretion of apolipoprotein E by cultured human keratinocytes. J. Invest. Dermatol. 92: 96 99, 1989.
18. 18 Fenjves E.S., Gordon D.A., Pershing L.K., et al. Systemic distribution of apolipoprotein E secreted by grafts of epidermal keratinocytes: Implications for epidermal function and gene therapy. Proc. Natl. Acad. Sci. U.S.A. 86: 8803 8807, 1989.
19. 19 Fenjves E.S., Smith J., Zaradic S., Taichman L.B. Systemic delivery of secreted protein by grafts of epidermal keratinocytes: Prospects for keratinocyte gene therapy. Hum. Gene Ther. 5: 1241 1248, 1994.
20. 20 Banks‐Schlegel S. & Green H. Formation of epidermis by serially cultivated human epidermal cells transplanted as an epithelium to athymic mice. Transplantation 29: 308 313, 1980.
21. 21 Alexander M.Y., Bidichandani S.I., Cousins F.M., et al. Circulating human factor IX produced in keratin‐promoter transgenic mice: A feasibility study for gene therapy of haemophilia B. Hum. Mol. Genet. 4: 993 999, 1995.
22. 22 Mathor M.B., Ferrari G., Dellambra E., et al. Clonal analysis of stably transduced human epidermal stem cells in culture. Proc. Natl. Acad. Sci. U.S.A. 93: 10371 10376, 1996.
23. 23 Supersaxo A., Hein W.R., Steffen H. Effect of molecular weight of the lymphatic absorption of water‐soluble compounds following subcutaneous administration. Pharm. Res. 7: 167 169, 1990.
24. 24 Gerrard A.J., Austen D.E.G., Brownlee G.G. Subcutaneous injection of factor IX for the treatment of haemophilia B. Br. J. Haematol. 81: 610 613, 1992.
25. 25 Simons K. & Wandinger‐Ness A. Polarized sorting in epithelia. Cell 62: 207 210, 1990.
26. 26 Marchisio P.C., Bondanza S., Cremona O., et al. Polarized expression of integrin receptors (α 6 β 4, α 2 β 1, α 3 β 1, and α v β 5) and their relationship with the cytoskeleton and basement membrane matrix in cultured human keratinocytes. J. Cell Biol. 112: 761 773, 1991.
27. 27 Fakharzadeh S., Sarkar R., Zhang Y., Kazazian Jr. H. Correction of factor VIII deficiency in a murine model for hemophilia A through targeting factor VIII transgene expression to epidermis [abstract]. J. Invest. Dermatol. 110: 503, 1998.
28. 28 Page S.M. & Brownlee G.G. An ex vivo keratinocyte model for gene therapy of hemophilia B. J. Invest. Dermatol. 109: 139 145, 1997.
29. 29 Page S.M. & Brownlee G.G. Differentiation‐specific enhancer activity in transduced keratinocytes: A model for epidermal gene therapy. Gene Ther. 5: 394 402, 1998.
30. 30 Deng H., Lin Q., Khavari P.A. Sustainable cutaneous gene delivery. Nat. Biotechnol. 15: 1388 1391, 1997.
31. 31 Kolodka T.M., Garlick J.A., Taichman L.B. Evidence for keratinocyte stem cells in vitro: Long term engraftment and persistence of transgene expression from retrovirus‐transduced keratinocytes. Proc. Natl. Acad. Sci. U.S.A. 95: 4356 4361, 1998.
32. 32 Fenjves E.S., Yao S.‐N., Kurachi K., Taichman L.B. Analysis of loss of expression of a retrovirus‐transduced gene in grafted human keratinocytes. J. Invest. Dermatol. 106: 576 578, 1996.
33. 33 Gerrard A.J., Hudson D.L., Brownlee G.G., Watt F.M. Towards gene therapy for haemophilia B using primary human keratinocytes. Nat. Genet. 3: 180 183, 1993.
34. 34 Setoguchi Y., Jaffe H.A., Danel C., Crystal R.G. Ex vivo and in vivo gene transfer to the skin using replication‐deficient recombinant adenovirus vectors. J. Invest. Dermatol. 102: 415 421, 1994.
35. 35 Morgan J.R., Barrandon Y., Green H., Mulligan R.C. Expression of an exogenous growth hormone gene by transplantable human epidermal cells. Science 237: 1476 1479, 1987.
36. 36 Teumer J., Lindahl A., Green H. Human growth hormone in the blood of athymic mice grafted with cultures of hormone‐secreting human keratinocytes. FASEB J. 4: 3245 3250, 1990.
37. 37 Xiaoming W., Zinkel S., Polonsky K., Fuchs E. Transgenic studies with a keratin promoter‐driven growth hormone transgene: Prospects for gene therapy. Proc. Natl. Acad. Sci. U.S.A. 94: 219 226, 1997.